Logo image of ARN.MI

ALERION CLEANPOWER (ARN.MI) Stock Fundamental Analysis

BIT:ARN - Euronext Milan - IT0004720733 - Common Stock - Currency: EUR

19.08  +0.48 (+2.58%)

Fundamental Rating

6

ARN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 19 industry peers in the Independent Power and Renewable Electricity Producers industry. While ARN has a great profitability rating, there are quite some concerns on its financial health. ARN is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year ARN was profitable.
ARN had a positive operating cash flow in the past year.
In the past 5 years ARN has always been profitable.
ARN had a positive operating cash flow in each of the past 5 years.
ARN.MI Yearly Net Income VS EBIT VS OCF VS FCFARN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

ARN's Return On Assets of 5.66% is amongst the best of the industry. ARN outperforms 89.47% of its industry peers.
Looking at the Return On Equity, with a value of 26.12%, ARN belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
ARN has a better Return On Invested Capital (8.49%) than 94.74% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ARN is significantly above the industry average of 4.73%.
Industry RankSector Rank
ROA 5.66%
ROE 26.12%
ROIC 8.49%
ROA(3y)5.37%
ROA(5y)4.85%
ROE(3y)23.57%
ROE(5y)21.49%
ROIC(3y)9.83%
ROIC(5y)8.05%
ARN.MI Yearly ROA, ROE, ROICARN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

ARN's Profit Margin of 42.86% is amongst the best of the industry. ARN outperforms 84.21% of its industry peers.
ARN's Profit Margin has improved in the last couple of years.
ARN has a better Operating Margin (59.54%) than 94.74% of its industry peers.
ARN's Operating Margin has improved in the last couple of years.
ARN has a better Gross Margin (94.20%) than 89.47% of its industry peers.
In the last couple of years the Gross Margin of ARN has remained more or less at the same level.
Industry RankSector Rank
OM 59.54%
PM (TTM) 42.86%
GM 94.2%
OM growth 3Y4.83%
OM growth 5Y9.01%
PM growth 3Y9.32%
PM growth 5Y7.35%
GM growth 3Y-1.32%
GM growth 5Y-0.55%
ARN.MI Yearly Profit, Operating, Gross MarginsARN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ARN is creating value.
Compared to 1 year ago, ARN has less shares outstanding
ARN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARN is higher compared to a year ago.
ARN.MI Yearly Shares OutstandingARN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ARN.MI Yearly Total Debt VS Total AssetsARN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ARN has an Altman-Z score of 1.25. This is a bad value and indicates that ARN is not financially healthy and even has some risk of bankruptcy.
ARN's Altman-Z score of 1.25 is in line compared to the rest of the industry. ARN outperforms 52.63% of its industry peers.
ARN has a Debt/Equity ratio of 2.38. This is a high value indicating a heavy dependency on external financing.
ARN has a worse Debt to Equity ratio (2.38) than 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.38
Debt/FCF N/A
Altman-Z 1.25
ROIC/WACC1.59
WACC5.33%
ARN.MI Yearly LT Debt VS Equity VS FCFARN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.89 indicates that ARN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.89, ARN is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
ARN has a Quick Ratio of 1.84. This is a normal value and indicates that ARN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ARN (1.84) is better than 78.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.84
ARN.MI Yearly Current Assets VS Current LiabilitesARN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

ARN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.21%, which is quite impressive.
Measured over the past years, ARN shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.73% on average per year.
The Revenue has grown by 36.33% in the past year. This is a very strong growth!
The Revenue has been growing by 26.12% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)44.21%
EPS 3Y25.61%
EPS 5Y33.73%
EPS Q2Q%370.08%
Revenue 1Y (TTM)36.33%
Revenue growth 3Y14.58%
Revenue growth 5Y26.12%
Sales Q2Q%83.03%

3.2 Future

Based on estimates for the next years, ARN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.95% on average per year.
ARN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.39% yearly.
EPS Next Y-44.44%
EPS Next 2Y-14.78%
EPS Next 3Y1.86%
EPS Next 5Y13.95%
Revenue Next Year4.44%
Revenue Next 2Y9.39%
Revenue Next 3Y11.52%
Revenue Next 5Y16.39%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ARN.MI Yearly Revenue VS EstimatesARN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
ARN.MI Yearly EPS VS EstimatesARN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ARN is valuated reasonably with a Price/Earnings ratio of 10.66.
Based on the Price/Earnings ratio, ARN is valued a bit cheaper than 73.68% of the companies in the same industry.
ARN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
The Price/Forward Earnings ratio is 18.43, which indicates a rather expensive current valuation of ARN.
ARN's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 36.28. ARN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.66
Fwd PE 18.43
ARN.MI Price Earnings VS Forward Price EarningsARN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ARN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ARN is cheaper than 63.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.7
ARN.MI Per share dataARN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

ARN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y-14.78%
EPS Next 3Y1.86%

More info and screens

6

5. Dividend

5.1 Amount

ARN has a Yearly Dividend Yield of 3.19%.
Compared to an average industry Dividend Yield of 3.71, ARN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, ARN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.19%

5.2 History

The dividend of ARN is nicely growing with an annual growth rate of 78.76%!
Dividend Growth(5Y)78.76%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

34.74% of the earnings are spent on dividend by ARN. This is a low number and sustainable payout ratio.
The dividend of ARN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.74%
EPS Next 2Y-14.78%
EPS Next 3Y1.86%
ARN.MI Yearly Income VS Free CF VS DividendARN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M
ARN.MI Dividend Payout.ARN.MI Dividend Payout, showing the Payout Ratio.ARN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

ALERION CLEANPOWER

BIT:ARN (8/5/2025, 7:00:00 PM)

19.08

+0.48 (+2.58%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)07-30 2025-07-30
Earnings (Next)11-13 2025-11-13
Inst Owners0.82%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.03B
Analysts84
Price Target24.48 (28.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.19%
Yearly Dividend0.62
Dividend Growth(5Y)78.76%
DP34.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.35%
PT rev (3m)4.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)22.58%
Revenue NY rev (3m)22.58%
Valuation
Industry RankSector Rank
PE 10.66
Fwd PE 18.43
P/S 4.63
P/FCF N/A
P/OCF 17.54
P/B 2.82
P/tB 10.28
EV/EBITDA 9.7
EPS(TTM)1.79
EY9.38%
EPS(NY)1.04
Fwd EY5.43%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)1.09
OCFY5.7%
SpS4.12
BVpS6.76
TBVpS1.86
PEG (NY)N/A
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 5.66%
ROE 26.12%
ROCE 10.04%
ROIC 8.49%
ROICexc 10.44%
ROICexgc 13.87%
OM 59.54%
PM (TTM) 42.86%
GM 94.2%
FCFM N/A
ROA(3y)5.37%
ROA(5y)4.85%
ROE(3y)23.57%
ROE(5y)21.49%
ROIC(3y)9.83%
ROIC(5y)8.05%
ROICexc(3y)15.03%
ROICexc(5y)11.56%
ROICexgc(3y)21.72%
ROICexgc(5y)16.52%
ROCE(3y)11.63%
ROCE(5y)9.53%
ROICexcg growth 3Y28.39%
ROICexcg growth 5Y34%
ROICexc growth 3Y22.23%
ROICexc growth 5Y30.27%
OM growth 3Y4.83%
OM growth 5Y9.01%
PM growth 3Y9.32%
PM growth 5Y7.35%
GM growth 3Y-1.32%
GM growth 5Y-0.55%
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 2.38
Debt/FCF N/A
Debt/EBITDA 4.69
Cap/Depr 159.37%
Cap/Sales 37.73%
Interest Coverage 4.74
Cash Conversion 31.72%
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 1.84
Altman-Z 1.25
F-Score7
WACC5.33%
ROIC/WACC1.59
Cap/Depr(3y)142.88%
Cap/Depr(5y)116.61%
Cap/Sales(3y)34.77%
Cap/Sales(5y)29.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.21%
EPS 3Y25.61%
EPS 5Y33.73%
EPS Q2Q%370.08%
EPS Next Y-44.44%
EPS Next 2Y-14.78%
EPS Next 3Y1.86%
EPS Next 5Y13.95%
Revenue 1Y (TTM)36.33%
Revenue growth 3Y14.58%
Revenue growth 5Y26.12%
Sales Q2Q%83.03%
Revenue Next Year4.44%
Revenue Next 2Y9.39%
Revenue Next 3Y11.52%
Revenue Next 5Y16.39%
EBIT growth 1Y36.08%
EBIT growth 3Y20.12%
EBIT growth 5Y37.49%
EBIT Next Year23.24%
EBIT Next 3Y18.77%
EBIT Next 5Y7.61%
FCF growth 1Y-186.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.57%
OCF growth 3Y-20.38%
OCF growth 5Y-1.87%